These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27282802)

  • 1. A novel SMARCAL1 missense mutation that affects splicing in a severely affected Schimke immunoosseous dysplasia patient.
    Barraza-García J; Rivera-Pedroza CI; Belinchón A; Fernández-Camblor C; Valenciano-Fuente B; Lapunzina P; Heath KE
    Eur J Med Genet; 2016 Aug; 59(8):363-6. PubMed ID: 27282802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel splice site mutation in SMARCAL1 results in aberrant exon definition in a child with Schimke immunoosseous dysplasia.
    Carroll C; Hunley TE; Guo Y; Cortez D
    Am J Med Genet A; 2015 Oct; 167A(10):2260-4. PubMed ID: 25943327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD).
    Santangelo L; Gigante M; Netti GS; Diella S; Puteo F; Carbone V; Grandaliano G; Giordano M; Gesualdo L
    BMC Nephrol; 2014 Mar; 15():41. PubMed ID: 24589093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel SMARCAL1 bi-allelic mutations associated with a chromosomal breakage phenotype in a severe SIOD patient.
    Simon AJ; Lev A; Jeison M; Borochowitz ZU; Korn D; Lerenthal Y; Somech R
    J Clin Immunol; 2014 Jan; 34(1):76-83. PubMed ID: 24197801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [SMARCAL1 gene analysis of 2 Chinese Schimke immuno-osseous dysplasia children].
    Wang W; Song H; Wei M; Qiu Z; Wang C; Zhang Y; Li M; Yuan Y; Tang X
    Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):45-50. PubMed ID: 25748404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low renal but high extrarenal phenotype variability in Schimke immuno-osseous dysplasia.
    Lipska-Ziętkiewicz BS; Gellermann J; Boyer O; Gribouval O; Ziętkiewicz S; Kari JA; Shalaby MA; Ozaltin F; Dusek J; Melk A; Bayazit AK; Massella L; Hyla-Klekot L; Habbig S; Godron A; Szczepańska M; Bieniaś B; Drożdż D; Odeh R; Jarmużek W; Zachwieja K; Trautmann A; Antignac C; Schaefer F;
    PLoS One; 2017; 12(8):e0180926. PubMed ID: 28796785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of neurologic and cutaneous signs in the diagnosis of Schimke immuno-osseous dysplasia.
    Polat Aİ; Yiş U; Ayanoğlu M; Hız AS; Güleryüz H; Öztürk Atasoy T; Boerkoel CF
    Turk J Pediatr; 2015; 57(5):509-13. PubMed ID: 27411420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schimke Immunoosseous Dysplasia associated with undifferentiated carcinoma and a novel SMARCAL1 mutation in a child.
    Carroll C; Badu-Nkansah A; Hunley T; Baradaran-Heravi A; Cortez D; Frangoul H
    Pediatr Blood Cancer; 2013 Sep; 60(9):E88-90. PubMed ID: 23630135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracheobronchial anomalies in a patient with Schimke immuno-osseous dysplasia (SIOD).
    Mobeireek A; Saleemi S; Khalid M; Imtiaz F; Almutairy EA
    Am J Med Genet A; 2015 Feb; 167A(2):434-7. PubMed ID: 25428399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schimke immune-osseous dysplasia: A case report.
    Bakr A; Eid R; Sarhan A; Hammad A; El-Refaey AM; El-Mougy A; Zedan MM; ElHusseini F
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):987-91. PubMed ID: 26354575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schimke immunoosseous dysplasia and management considerations for vascular risks.
    Beleford DT; Diab M; Qubty WF; Malloy MJ; Long RK; Shieh JT
    Am J Med Genet A; 2019 Jul; 179(7):1246-1252. PubMed ID: 31039288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated multiplex ligation dependent probe amplification (MLPA) assays for the detection of alterations in the HEXB, GM2A and SMARCAL1 genes to support the diagnosis of Morbus Sandhoff, M. Tay-Sachs variant AB and Schimke immuno-osseous dysplasia in humans.
    Sobek AK; Evers C; Dekomien G
    Mol Cell Probes; 2013 Feb; 27(1):32-7. PubMed ID: 23010210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Wnt and Notch signaling: a clue to the renal disease in Schimke immuno-osseous dysplasia?
    Morimoto M; Myung C; Beirnes K; Choi K; Asakura Y; Bokenkamp A; Bonneau D; Brugnara M; Charrow J; Colin E; Davis A; Deschenes G; Gentile M; Giordano M; Gormley AK; Govender R; Joseph M; Keller K; Lerut E; Levtchenko E; Massella L; Mayfield C; Najafian B; Parham D; Spranger J; Stenzel P; Yis U; Yu Z; Zonana J; Hendson G; Boerkoel CF
    Orphanet J Rare Dis; 2016 Nov; 11(1):149. PubMed ID: 27816064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatin changes in SMARCAL1 deficiency: A hypothesis for the gene expression alterations of Schimke immuno-osseous dysplasia.
    Morimoto M; Choi K; Boerkoel CF; Cho KS
    Nucleus; 2016 Nov; 7(6):560-571. PubMed ID: 27813696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of IL7Rα expression in T cells is a hallmark of T-cell immunodeficiency in Schimke immuno-osseous dysplasia (SIOD).
    Sanyal M; Morimoto M; Baradaran-Heravi A; Choi K; Kambham N; Jensen K; Dutt S; Dionis-Petersen KY; Liu LX; Felix K; Mayfield C; Dekel B; Bokenkamp A; Fryssira H; Guillen-Navarro E; Lama G; Brugnara M; Lücke T; Olney AH; Hunley TE; Polat AI; Yis U; Bogdanovic R; Mitrovic K; Berry S; Najera L; Najafian B; Gentile M; Nur Semerci C; Tsimaratos M; Lewis DB; Boerkoel CF
    Clin Immunol; 2015 Dec; 161(2):355-65. PubMed ID: 26499378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel compound heterozygous variant in
    Wang L; Li J; Wu G; Kong X
    J Int Med Res; 2021 Apr; 49(4):3000605211010644. PubMed ID: 33900868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R561C missense mutation in the SMARCAL1 gene associated with mild Schimke immuno-osseous dysplasia.
    Bökenkamp A; deJong M; van Wijk JA; Block D; van Hagen JM; Ludwig M
    Pediatr Nephrol; 2005 Dec; 20(12):1724-8. PubMed ID: 16237566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of helicase C-terminal domain of SMARCAL1 protein associated with severe Schimke immuno-osseous dysplasia.
    Gharesouran J; Hosseinzadeh H; Ghergherechi R; Shiva S; Taheri M; Liehr T; Rezazadeh M
    Pathol Res Pract; 2024 Feb; 254():155092. PubMed ID: 38218042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the renal pathogenesis in Schimke immuno-osseous dysplasia: A renal histological characterization and expression analysis.
    Sarin S; Javidan A; Boivin F; Alexopoulou I; Lukic D; Svajger B; Chu S; Baradaran-Heravi A; Boerkoel CF; Rosenblum ND; Bridgewater D
    J Histochem Cytochem; 2015 Jan; 63(1):32-44. PubMed ID: 25319549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-induced conformation changes drive ATP hydrolysis and function in SMARCAL1.
    Gupta M; Mazumder M; Dhatchinamoorthy K; Nongkhlaw M; Haokip DT; Gourinath S; Komath SS; Muthuswami R
    FEBS J; 2015 Oct; 282(19):3841-59. PubMed ID: 26195148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.